Cannabinoid Innovation

 

CANNABIS PRODUCTS DEVELOPED IN ISRAEL

Crafted in the UK to EU Standards

 

Partnering with Leading Institutions

 

CUTTING-EDGE CANNABIS PRODUCTS

Supported by Clinical Research

 

ISRAELI RESEARCH

Products Made in UK

CANNABIS PRODUCTS

Clinical Research

CBD PRODUCTS

CIITECH is the first and only company developing & distributing Israeli cannabis products overseas.  Through our UK operation and eCommerce store EssentialCannabinoids.co.uk, CIITECH delivers best of breed cannabis therapeutics to global consumers.

PROVACAN CBD Oils

Our Flagship Israeli Brand

ProVacan, our range of hemp derived CBD products serving the need of customers seeking a reliable brand supported by strong company ethics and on continued scientific research.

HERBALICA Botanicals

Herbal Remedy with CBD

CIITECH has launched the HERBALICA CBD range combining traditional herbal remedies with cannabis.  Developed in Israel from years of botanical extract research.

VAPEPOD

Medical device ‘approved’ vaporizer

CIITECH has partnered with Kanabo Research to develop VAPEPOD CBD a state-of-the-art device for effective vaporization of essential cannabinoids.  The Future of Vaporization is Here!

EXPORTING ISRAELI CANNABIS INNOVATION

CIITECH partners with leading institutions and companies in Israel and the UK to leverage cutting-edge cannabis science and clinical research. Our mission is to craft unique cannabis therapeutic products that can help a wide range of indications.

Our vision is to contribute to the future where people are free to choose between physician prescribed cannabinoid-based pharmaceuticals or nutraceutical & wellness products on recommendation & anecdotal evidence.

WHAT WE DO

 SCIENTIFIC RESEARCH

CIITECH has partnered with the leading Israeli academic institution for cannabinoid research.

Through research the profile of hundreds of molecules are isolated and analysed. Through science, we gain clarity to advance towards effective therapeutic products.

 NOVEL FORMULATIONS

CIITECH’s partners include leading Israeli scientists and pharmaceutical experts.

Together with our UK production partner, we are creating new and novel cannabinoid formulations for the wellness market with the precision and consistency of clinically validated medicine.

 DELIVERY MECHANISMS

CIITECH identifies innovative optimal delivery mechanisms for optimal bioavailability.

We have partnered with an Israeli based medical cannabis biotech company to bring the UK and Europe a high-quality, safe and reliable medical grade vaporizer, suitable for CBD and CBG.

RESEARCH & FOCUS

CIITECH is investigating a wide spectrum of minor cannabinoids and combination profiles for multiple application and delivery mechanisms. Our initial studies will focus on the use of canabidiol (CBD) as primary molecule.

Whilst potential medical applications are wide ranging, our areas of focus are; dermatalogical, digestive and neurological disorders.

HEALTHCARE

Inflammation as the root cause of many human ailments

Obesity & Diabetes together with related metabolism disorders.

Psoriasis & Eczema together with related dermatological conditions

CANNABINOIDS

Cannabidiol. CBD is a non-psychoactive cannabinoid. CBD is 100% legal in the UK & EU when extracted from industrial hemp.

Combinations.  Testing the entourage effects of combining cannabinoids, terpenoids and other known molecules.

CONTACT US

CIITECH leverages Israeli excellence in research, medical advancements, and cannabis innovation to provide the UK and Europe with the know-how to produce and market therapeutic cannabis-based products.  Get in touch with us – we would love to hear from you!

5 + 11 =